5621-01-2

Usage

Uses

Used in Agricultural Industry:
6-chloro-N,2-dimethyl-4-pyrimidinamine is used as a herbicide for controlling the growth of grassy and broadleaf weeds. Its application helps improve crop yields by reducing competition for resources between weeds and desired crops.
However, it is important to note that 6-chloro-N,2-dimethyl-4-pyrimidinamine can be toxic to aquatic organisms and may have adverse effects on the environment if not used properly. Therefore, caution must be exercised in its application to minimize potential harm to non-target species and ecosystems.

InChI:InChI=1/C16H15N5O2S/c1-11-2-6-13(7-3-11)15-18-19-16(20(15)17)24-10-12-4-8-14(9-5-12)21(22)23/h2-9H,10,17H2,1H3

Upstream product

• 1780-26-3 2,4-dichloro-2-methylpyrimidine 
• 74-89-5 methylamine 
• 593-51-1 methylamine hydrochloride 

Relevant academic research and scientific papers

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS

The present disclosure relates to amine-substituted aryl or heteroaryl compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., sickle cell anemia) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2, by administering an amine-substituted aryl or heteroaryl compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

The present invention encompasses novel substituted pyrimidine compounds of Formula (I): which act as MCH receptor antagonists. These compounds are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson’s disease, epilepsy, and addiction.